Literature DB >> 8350866

Effects of vanadate administration on the high sucrose diet-induced aberrations in normal rats.

S Pugazhenthi1, J F Angel, R L Khandelwal.   

Abstract

Effects of feeding sucrose rich diet supplemented with and without the insulinmimetic agent vanadate for a period of six weeks were studied in rats. Sucrose diet caused hypertriglyceridemia (140% increase), hyperinsulinemia (120% increase) and significant elevations in the levels of glucose (p < 0.001) and cholesterol (p < 0.05) in plasma as compared to control starch fed rats. Activities of hepatic lipogenic enzymes, ATP-citrate lyase, glucose 6-phosphate dehydrogenase and malic enzyme increased by 100-150% as a result of sucrose feeding. However, glycogen content and the activities of glycogen synthase and phosphorylase in liver remained unaltered in these animals. The plasma levels of triacylglycerols and insulin in the rats fed on vanadate supplemented sucrose diet were 65% and 85% less, respectively as compared to rats on sucrose diet without vanadate. The concentrations of glucose and cholesterol in plasma and the activities of lipogenic enzymes in liver did not show any elevation in sucrose fed rats when supplemented with vanadate. These data indicate that the sucrose diet-induced metabolic aberrations can be prevented by the insulin-mimetic agent, vanadate.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8350866     DOI: 10.1007/bf00925739

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  44 in total

1.  Hepatic insulin responsiveness in patients with endogenous hypertriglyceridaemia.

Authors:  R M Bernstein; B M Davis; J M Olefsky; G M Reaven
Journal:  Diabetologia       Date:  1978-04       Impact factor: 10.122

2.  Effects of nutrients and insulin on transcriptional and post-transcriptional regulation of glucose-6-phosphate dehydrogenase synthesis in rat liver.

Authors:  A Katsurada; N Iritani; H Fukuda; Y Matsumura; T Noguchi; T Tanaka
Journal:  Biochim Biophys Acta       Date:  1989-11-06

3.  Increasing effect of vanadate on lipoprotein lipase activity in isolated rat fat pads.

Authors:  M Sera; K Tanaka; T Morita; H Ueki
Journal:  Arch Biochem Biophys       Date:  1990-06       Impact factor: 4.013

4.  Vanadate normalizes hyperglycemia in two mouse models of non-insulin-dependent diabetes mellitus.

Authors:  J Meyerovitch; P Rothenberg; Y Shechter; S Bonner-Weir; C R Kahn
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

5.  Effects of fructose, levamisole and vanadate on insulin action in rat adipose tissue.

Authors:  S R Blakely; A O Akintilo; R H Pointer
Journal:  J Nutr       Date:  1987-03       Impact factor: 4.798

6.  Fatty acid metabolism and lipid secretion by perfused livers from rats fed laboratory stock and sucrose-rich diets.

Authors:  M Yamamoto; I Yamamoto; Y Tanaka; J A Ontko
Journal:  J Lipid Res       Date:  1987-10       Impact factor: 5.922

7.  Effects of chronic administration of vanadate to the rat on the sensitivity of glycolysis and glycogen synthesis in skeletal muscle to insulin.

Authors:  R A Challiss; B Leighton; F J Lozeman; L Budohoski; E A Newsholme
Journal:  Biochem Pharmacol       Date:  1987-02-01       Impact factor: 5.858

8.  Blood lipid distribution of hyperinsulinemic men consuming three levels of fructose.

Authors:  J Hallfrisch; S Reiser; E S Prather
Journal:  Am J Clin Nutr       Date:  1983-05       Impact factor: 7.045

9.  Partial characterization of the fructose-induced defect in very-low-density lipoprotein triglyceride metabolism.

Authors:  J C Mamo; T Hirano; L James; L Szeto; G Steiner
Journal:  Metabolism       Date:  1991-09       Impact factor: 8.694

10.  Studies of the mechanism of fructose-induced hypertriglyceridemia in the rat.

Authors:  I Zavaroni; Y D Chen; G M Reaven
Journal:  Metabolism       Date:  1982-11       Impact factor: 8.694

View more
  8 in total

Review 1.  The vital role of ATP citrate lyase in chronic diseases.

Authors:  Amrita Devi Khwairakpam; Kishore Banik; Sosmitha Girisa; Bano Shabnam; Mehdi Shakibaei; Lu Fan; Frank Arfuso; Javadi Monisha; Hong Wang; Xinliang Mao; Gautam Sethi; Ajaikumar B Kunnumakkara
Journal:  J Mol Med (Berl)       Date:  2019-12-19       Impact factor: 4.599

2.  In vivo effects of vanadate on hepatic glycogen metabolizing and lipogenic enzymes in insulin-dependent and insulin-resistant diabetic animals.

Authors:  R L Khandelwal; S Pugazhenthi
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

3.  Vanadate induces normolipidemia and a reduction in the levels of hepatic lipogenic enzymes in obese Zucker rat.

Authors:  S Pugazhenthi; A Hussain; B Yu; R W Brownsey; J F Angel; R L Khandelwal
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

4.  Effect of different types of high carbohydrate diets on glycogen metabolism in liver and skeletal muscle of endurance-trained rats.

Authors:  G Garrido; M Guzmán; J M Odriozola
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

5.  A minipig model of high-fat/high-sucrose diet-induced diabetes and atherosclerosis.

Authors:  Shoumin Xi; Weidong Yin; Zongbao Wang; Masataka Kusunoki; Xin Lian; Tomonari Koike; Jianglin Fan; Qiuju Zhang
Journal:  Int J Exp Pathol       Date:  2004-10       Impact factor: 1.925

6.  Effects of high sucrose diet on insulin-like effects of vanadate in diabetic rats.

Authors:  S Pugazhenthi; J F Angel; R L Khandelwal
Journal:  Mol Cell Biochem       Date:  1993-05-12       Impact factor: 3.396

7.  Does the insulin-mimetic action of vanadate involve insulin receptor kinase?

Authors:  S Pugazhenthi; R L Khandelwal
Journal:  Mol Cell Biochem       Date:  1993-11       Impact factor: 3.396

Review 8.  Vanadium in Biological Action: Chemical, Pharmacological Aspects, and Metabolic Implications in Diabetes Mellitus.

Authors:  Samuel Treviño; Alfonso Díaz; Eduardo Sánchez-Lara; Brenda L Sanchez-Gaytan; Jose Manuel Perez-Aguilar; Enrique González-Vergara
Journal:  Biol Trace Elem Res       Date:  2018-10-22       Impact factor: 3.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.